Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Haematologica|February 14, 2007
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemiaWanlong Ma, Richard Tseng, Mercedes Gorre, et al.
Leukemia Research|September 23, 2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)Ellin Berman, Suresh Jhanwar, Cyrus Hedvat, et al.
Cancer|March 29, 2002
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative diseaseFrancesco DiRaimondo, Maher Albitar, Yang Huh, et al.
Leukemia Research|December 25, 2007
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activationIman Jilani, Hagop Kantarjian, Homan Faraji, et al.
Scandinavian Journal of Urology|March 4, 2026
Plasma and urine biomarker algorithm versus systematic biopsy for prostate cancer detection in elderly men: a randomised trial with early termination for futilityTorben Brøchner Pedersen, Charlotte Aaberg Poulsen, Martin Lund, et al.
Leukemia Research|April 6, 2010
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemiaJean-Marie Bruey, Hagop Kantarjian, Wanlong Ma, et al.
Cancer|October 10, 2003
The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndromeBarry D Hock, Judith L McKenzie, William Nigel Patton, et al.
Pageof 21